特発性血小板減少性紫斑病の人の平均余命はどれくらいですか?

特発性血小板減少性紫斑病の人々の平均余命および特発性血小板減少性紫斑病における最近の進歩および研究

元の


Most adult patients with ITP have a good outcome with infrequent hospital admissions and no excess mortality compared with the general population. However, patients with persistent severe thrombocytopenia not responding to therapy within the first 2 years have considerable morbidity and mortality.

Translated